
    
      In this study we will describe

        -  habits of medical staff in prescription of growth factors or antibiotic prophylaxis

        -  ratio of patients treated by growth factors in primary or secondary prophylaxis

        -  ratio of patients treated in primary prophylaxis who present a febrile neutropenia

        -  ratio of patients who need to be hospitalized and the duration of those
           hospitalizations.

        -  causes of lateness, of decreasing, and of stop of chemotherapy

        -  antibiotic and growth factors prophylaxis tolerance .
    
  